Aviron (Biotechnology) Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
462
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.5B
Aviron (Biotechnology) General Information
Description
Developer of vaccine technologies focused on prevention of disease. The company's product portfolio includes fluMist, a live virus vaccine delivered as a nasal mist for the prevention of influenza, a live parainfluenza virus type 3 vaccine, a vaccine to prevent epstein-barr virus and a cytomegalovirus vaccine.
Contact Information
Corporate Office
- 297 North Bernardo Avenue
- Mountain View, CA 94043
- United States
Corporate Office
- 297 North Bernardo Avenue
- Mountain View, CA 94043
- United States
Aviron (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 15-Jan-2002 | $1.5B | Completed | Generating Revenue | ||
| 6. PIPE | 12-Jun-2000 | Completed | Generating Revenue | |||
| 5. PIPE | 01-Apr-1997 | Completed | Generating Revenue | |||
| 4. IPO | 05-Nov-1996 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 01-Mar-1996 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Jul-1993 | $15M | $17.5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Jul-1992 | $2.5M | $2.5M | Completed | Generating Revenue |
Aviron (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aviron (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aviron (Biotechnology) Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | ||
| Abingworth | Venture Capital | Minority | ||
| Accel | Venture Capital | Minority | ||
| Acqua Wellington | PE/Buyout | Minority | ||
| Adams Street Partners | PE/Buyout | Minority |
Aviron (Biotechnology) FAQs
-
When was Aviron (Biotechnology) founded?
Aviron (Biotechnology) was founded in 1992.
-
Where is Aviron (Biotechnology) headquartered?
Aviron (Biotechnology) is headquartered in Mountain View, CA.
-
What is the size of Aviron (Biotechnology)?
Aviron (Biotechnology) has 462 total employees.
-
What industry is Aviron (Biotechnology) in?
Aviron (Biotechnology)’s primary industry is Biotechnology.
-
Is Aviron (Biotechnology) a private or public company?
Aviron (Biotechnology) is a Private company.
-
What is the current valuation of Aviron (Biotechnology)?
The current valuation of Aviron (Biotechnology) is .
-
What is Aviron (Biotechnology)’s current revenue?
The current revenue for Aviron (Biotechnology) is .
-
How much funding has Aviron (Biotechnology) raised over time?
Aviron (Biotechnology) has raised $58.2M.
-
Who are Aviron (Biotechnology)’s investors?
ARCH Venture Partners, Abingworth, Accel, Acqua Wellington, and Adams Street Partners are 5 of 12 investors who have invested in Aviron (Biotechnology).
-
When was Aviron (Biotechnology) acquired?
Aviron (Biotechnology) was acquired on 15-Jan-2002.
-
Who acquired Aviron (Biotechnology)?
Aviron (Biotechnology) was acquired by MedImmune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
